Publicado el boletín HIV This Week No. 96

Boletin HIV This WeekEste boletín es publicado por el Programa Conjunto de las Naciones Unidas Sobre el Sida, ONUSIDA. Los editores y especialistas de ese espacio realizan una exploración selectiva de información relacionada con el VIH publicada en revistas científicas. Luego interpretan los resúmenes originales y proporcionan un comentario, que no representa ninguna declaración oficial de ONUSIDA, pero promueve el debate y el análisis profesional sobre el tema. En idioma inglés. Puede suscribirse para recibirlo por correo electrónico. Este número comenta los siguientes temas:

1. Bisexuality in men who have sex with men

  • Bisexual behaviour in China: a first meta-analysis
  • Lower levels of bisexuality in peri-urban Cape Town

2. Ageing and HIV

  • Growing old with HIV: social and behavioural aspects

3. Microbicides

  • Rectal pre-exposure prophylaxis (rectal PrEP) trials: A novel way to measure ex vivo efficacy

4. Point of care testing

  • Detecting TB and MDR-TB in one sitting: the new molecular-based diagnostic methods for TB
  • Effect on pre-treatment losses of point-of-care CD4 cell count tests: what are we waiting for?

5. Faith-based responses

  • HIV prevention through treatment scale-up: how Pentecostalism can join the response in Mozambique

6. People living with HIV

  • Women could benefit from the HPV vaccine: insights from South Africa, Brazil, and Botswana

7. Epidemiology

  • Northern Greece: evidence of transmission clusters of dual drug resistance

8. Vaccines

  • Vectored immunoprophylaxis or VIP: a name you will be hearing more often in vaccine research

9. Cost effectiveness

  • • Malawi’s DREAM project demonstrates 3 drug regimen cost-effectiveness for PMTCT
  • The Haiti CIPRA trial reveals the cost-effectiveness of early versus standard antiretroviral therapy

10. Stigma

  • atent class analysis reveals community patterns of stigma in rural Vietnam
  • Mindfulness philosophy can help overcome stigma in health care providers

11. Discordant couples

  • Risk of HIV acquisition from outside sexual partners by HIV-negative people in HIV serodiscordant partnerships in Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, and Zambia

12. Civil society responses

  • HIV-prevention in criminalising environments: the case study of Alternatives-Cameroun

13. Male circumcision devices

  • Safety and efficacy of the PrePex™ device in Rwanda
  • Safety and acceptability of the Alisklamp® device in Kenya

14. National responses

  • 21 million treatment days in Germany: a huge database to calculate direct antiretroviral treatment costs and potential cost savings by using generics

Fuente
HIV This Week. Onusida